186 related articles for article (PubMed ID: 14575257)
1. Of hedgehogs and hereditary bone tumors: re-examination of the pathogenesis of osteochondromas.
Jones KB; Morcuende JA
Iowa Orthop J; 2003; 23():87-95. PubMed ID: 14575257
[TBL] [Abstract][Full Text] [Related]
2. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
3. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate as a regulator of endochondral ossification and osteochondroma development.
Jochmann K; Bachvarova V; Vortkamp A
Matrix Biol; 2014 Feb; 34():55-63. PubMed ID: 24370655
[TBL] [Abstract][Full Text] [Related]
5. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
6. The neoplastic pathogenesis of solitary and multiple osteochondromas.
Porter DE; Simpson AH
J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
8. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
[TBL] [Abstract][Full Text] [Related]
9. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
[TBL] [Abstract][Full Text] [Related]
10. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
[TBL] [Abstract][Full Text] [Related]
11. Signaling systems affecting the severity of multiple osteochondromas.
Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
[TBL] [Abstract][Full Text] [Related]
12. Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification.
Koziel L; Kunath M; Kelly OG; Vortkamp A
Dev Cell; 2004 Jun; 6(6):801-13. PubMed ID: 15177029
[TBL] [Abstract][Full Text] [Related]
13. Osteochondromas: review of the clinical, radiological and pathological features.
Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
[TBL] [Abstract][Full Text] [Related]
14. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
[TBL] [Abstract][Full Text] [Related]
15. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC
Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575
[TBL] [Abstract][Full Text] [Related]
16. Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.
Cuellar A; Reddi AH
Int Orthop; 2013 Aug; 37(8):1591-6. PubMed ID: 23771188
[TBL] [Abstract][Full Text] [Related]
17. Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage.
de Andrea CE; Prins FA; Wiweger MI; Hogendoorn PC
J Pathol; 2011 Jun; 224(2):160-8. PubMed ID: 21506131
[TBL] [Abstract][Full Text] [Related]
18. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
Pacifici M
Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.
de Andrea CE; Zhu JF; Jin H; Bovée JV; Jones KB
J Pathol; 2015 Jun; 236(2):210-8. PubMed ID: 25644707
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]